Rchr
J-GLOBAL ID:201901012510796245   Update date: Aug. 03, 2021

Suzuki Toshihiro

スズキ トシヒロ | Suzuki Toshihiro
Affiliation and department:
Other affiliations (3):
  • 帝京大学  アジア国際感染症制御研究所   講師(兼任)
  • 帝京大学  戦略的イノベーション開発センター   講師(兼任)
  • 国立がん研究センター  先端医療開発センター 免疫療法開発分野   外来研究員
Papers (42):
  • Satoshi Okubo, Toshihiro Suzuki, Masayoshi Hioki, Yasuhiro Shimizu, Hirochika Toyama, Soichiro Morinaga, Naoto Gotohda, Katsuhiko Uesaka, Genichiro Ishii, Shinichiro Takahashi, et al. The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer. Cancer science. 2021
  • Keigo Chida, Akihito Kawazoe, Masahito Kawazu, Toshihiro Suzuki, Yoshiaki Nakamura, Tetsuya Nakatsura, Takeshi Kuwata, Toshihide Ueno, Yasutoshi Kuboki, Daisuke Kotani, et al. A low tumor mutational burden and PTEN mutations are predictors of a negative response to PD-1 blockade in MSI-H/ dMMR gastrointestinal tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021
  • Hiroyasu Aoki, Satoshi Ueha, Shigeyuki Shichino, Haru Ogiwara, Kohei Shitara, Manami Shimomura, Toshihiro Suzuki, Tetsuya Nakatsura, Makiko Yamashita, Shigehisa Kitano, et al. Transient Depletion of CD4+ Cells Induces Remodeling of the TCR Repertoire in Gastrointestinal Cancer. Cancer immunology research. 2021
  • Ryo Morisue, Motohiro Kojima, Toshihiro Suzuki, Tetsuya Nakatsura, Hidenori Ojima, Reiko Watanabe, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, et al. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses. International journal of cancer. 2021
  • Miho Oka, Liu Xu, Toshihiro Suzuki, Toshiaki Yoshikawa, Hiromi Sakamoto, Hayato Uemura, Akiyasu C Yoshizawa, Yutaka Suzuki, Tetsuya Nakatsura, Yasushi Ishihama, et al. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer. Genome biology. 2021. 22. 1. 9-9
more...
MISC (5):
  • Shoichi Iida, Toshihiro Suzuki, Kazunari Tanabe, Anna Valujskikh, Robert Fairchild, Ryo Abe. TRANSIENT LYMPHOPENIA BREAKS COSTIMULATORY BLOCKADE-BASED TRANSPLANT TOLERANCE AND INITIATES ALLOGRAFT REJECTION. JOURNAL OF UROLOGY. 2015. 193. 4. E1073-E1073
  • Toshihiro Suzuki, Hidehiro Kishimoto, Ryo Abe. Initial IL7R signaling regulate the induction of effector CD8+T cells and subsequent anti-tumor immune response in lymphopenic host. JOURNAL OF IMMUNOLOGY. 2014. 192
  • Hidehiro Kishimoto, Tomoyoshi Yamanol, Toshihiro Suzuki, Ryo Abe. Ex-vivo expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin allografts. JOURNAL OF IMMUNOLOGY. 2011. 186
  • Shoichi Iida, Kazuya Omoto, Kazunari Tanabe, Toshihiro Suzuki, Hidehiro Kishimoto, Ryo Abe. Blockade of Interleukin-6 Receptor Signaling Prevents the Development of Cardiac Allograft Vasculopathy and Propes Allograft Survival in a Mice Model. AMERICAN JOURNAL OF TRANSPLANTATION. 2009. 9. 400-400
  • Toshihiro Suzuki, Hidehiro Kishimoto, Ryo Abe. Anti-tumor immune response induced by homeostatic proliferation and CD28 signaling. FASEB JOURNAL. 2008. 22
Professional career (2):
  • 博士(医学) (東京大学大学院)
  • 修士(薬学) (東京理科大学)
Work history (1):
  • 2021/04 - 現在 Teikyo University Department of Pharmacology, Teikyo University School of Medicine Department of Pharmacology, Teikyo University School of Medicine Assistant Professor
Association Membership(s) (2):
THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page